Genotropin Study Assessing Use of Injection Pen

Completed · Phase 3

Conditions studied: Growth Hormone Deficiency, Idiopathic Short Stature

In brief

Assessment of Genotropin patient and caregiver (Dyad) perception of convenience and preference of Genotropin injection pen. Patients already on genotropin will be asked to use a genotropin pen for 2 months. Patient and caregiver will be asked to complete a questionnaire at baseline and 2 months.

Key facts

Study ID

NCT00965484

Run by

Pfizer

People needed

136

Starts

2009-10-01

Expected to finish

2010-01-01

Last updated by the study team

2011-01-28

Who can join

Age: 8 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 8-18 years
• Using genotropin pen for at least 3 months prior to study enrollment
• Compliance with genotropin treatment

You may not qualify if…

• Medical conditions that can affect participation in study
• Insufficient command of English language to understand questionnaire
• Using other growth hormone device and not Genotropin pen

Where it is running

• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Greenwood Village, Colorado, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Tallahassee, Florida, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Southaven, Mississippi, United States
• Pfizer Investigational Site — Kansas City, Missouri, United States
• Pfizer Investigational Site — Morristown, New Jersey, United States
• Pfizer Investigational Site — Akron, Ohio, United States
• Pfizer Investigational Site — Columbus, Ohio, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
• Pfizer Investigational Site — Pittsburgh, Pennsylvania, United States
• Pfizer Investigational Site — Charleston, South Carolina, United States
• Pfizer Investigational Site — Florence, South Carolina, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Fort Worth, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.